Last reviewed · How we verify

NCT03460691

The Effect of Bariatric Surgery to Central Sensitization

Status unknown Last updated 9 March 2018
What this trial tests

trial testing Bariatric surgery in Bariatric Surgery in 50 participants. Status unknown.

Timeline
9 March 2018
Primary endpoint
9 December 2018
9 December 2018

Quick facts

Lead sponsorBursa Yuksek Ihtisas Training and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date9 March 2018
Primary completion9 December 2018
Estimated completion9 December 2018

Drugs / interventions tested

Conditions studied

Sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Who can join

Adults 18 to 75, any sex, with Bariatric Surgery or Central Sensitization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nowadays obesity is emerging as a very common health problem. It has been shown in various studies that obesity may be an important risk factor for the onset and progression of knee osteoarthritis (OA). The aim of this study is to determine the effects of bariatric surgery on knee pain, loss of function, quality of life and central sensitization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bariatric surgery

Trials testing the same drug.

Other recruiting trials for Bariatric Surgery

Currently open trials in the same condition.

Other Bursa Yuksek Ihtisas Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing